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The matrix protein (M) of vesicular stomatitis virus is responsible for the budding of newly formed virions out of host cells.
In vitro, it has been shown to self-associate, a property that may be related to the role of M in virus assembly but also
prevents crystallization. Using limited proteolysis by thermolysin, we have isolated and characterized two soluble fragments
of the protein that remain noncovalently associated. The digestion product does not self-associate nor is it recruited in
aggregates formed by intact M molecules. These results identify a peptide, located at the surface of the protein and
disorganized by thermolysin cleavage, responsible for M self-association. The thermolysin-resistant core of M has been
crystallized and the crystals diffract to 2-Å resolution. © 2001 Academic Press
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aINTRODUCTION
Enveloped viruses acquire their membrane by budding
at a membrane of their host cell. In many viral families,
including paramyxovirus, filovirus, orthomyxovirus, and
rhabdovirus, a protein, the matrix protein (M), is respon-
sible for budding. Vesicular stomatitis virus (VSV), the
prototype rhabdovirus, has been used as a model for this
process (Lenard, 1996). It is an enveloped virus with a
single-stranded RNA genome of negative polarity. The
genome associates with the nucleoprotein N, the viral
polymerase L, and the phosphoprotein P to form the
nucleocapsid. The nucleocapsid is condensed by the
matrix protein M into a tightly coiled helical structure,
which is surrounded by a lipid bilayer containing the viral
glycoprotein G.
In addition to its role in budding, the M protein (229 aa,
26.1 kDa) has multiple functions during the VSV viral
cycle. It is responsible for the condensation of the nu-
cleocapsid (Newcomb et al., 1982; Newcomb and Brown,
1981) and, as a consequence, for the inhibition of tran-
scription of the viral genome (Clinton et al., 1978; Marti-
net et al., 1979). The M protein is also involved in the
virus-induced inhibition of host cell transcription (Black
et al., 1994; Black and Lyles, 1992); this shut-off is prob-
ably induced by an effect of M on the transcription factor
TFIID, which was found to be ineffective in the cells
where M is expressed (Yuan et al., 1998). Eventually, M is
involved in the inhibition of the export of RNAs from thet
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308nucleus (Her et al., 1997; von Kobbe et al., 2000) and in
the rounding of infected cells characteristic of VSV infec-
tion (Blondel et al., 1990; Melki et al., 1994).
Studies of temperature-sensitive mutants led to the
conclusion that M domains responsible for budding and
host RNA shut-off differ (Black et al., 1993). More recently,
a PPPY motif located in the NH2-terminal domain of VSV
, conserved among Rhabdoviridae and also present in
he retrovirus GAG proteins and Ebola matrix protein, has
een shown to interact in vitro with proteins containing
W domains (Harty et al., 1999, 2000). Domain swapping
etween the GAG late domain of Rous sarcoma virus
nd the amino-terminal domain of M has suggested that
his PPPY motif could play the same role during the late
hase of budding of both viruses (Craven et al., 1999).
ndeed, VSV M PPPY motif mutagenesis affects the effi-
iency of release of virions from infected cells (Jayakar et
l., 2000).
Two biochemical properties of M are thought to be
elated to its role in viral assembly and budding. First, the
protein self-associates at physiological NaCl concen-
ration (McCreedy et al., 1990). This process is initiated
y trypsin-sensitive nucleation sites and can be reversed
y increasing the salt concentration (Gaudin et al., 1995).
elf-association could be important for nucleocapsid
ompaction; it may also constitute a driving force for the
udding process. Second, the M protein associates with
he cell membrane (Bergmann and Fusco, 1988; Chong
nd Rose, 1993, 1994). Hydrophobic photolabeling using
125I TID has suggested that the amino-terminal region of
he protein is involved in membrane association (Lenard
nd Vanderoef, 1990). However, M mutants in which the
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309CRYSTALLIZATION OF VSV MATRIX PROTEINamino-terminal domain has been deleted are still able to
interact with cellular membranes although the binding
seems to be less stable; thus, another region of the
protein seems to be involved in this interaction (Chong
and Rose, 1994; Ye et al., 1994).
In the absence of an atomic structure of M, the design
of mutations aimed at determining the domains involved
in the various functions of M is made difficult. Unfortu-
nately, due to its tendency to self-associate, M protein is
poorly soluble even at high salt concentrations (less than
3 mg/ml in 0.5 M NaCl), and it could not be crystallized
despite repeated attempts. We chose to use limited pro-
teolysis to isolate a fragment of VSV M for crystallization.
We describe here the procedure that has allowed us to
identify a soluble fragment of the VSV M protein that, as
opposed to M or to the M trypsin-resistant core (Gaudin
et al., 1995), is not recruited in M aggregates. This prod-
uct was purified, characterized, and crystallized; the
crystals diffract to 2-Å resolution.
FIG. 1. Limited proteolysis at 37°C of VSV M protein by trypsin (lane
2, 20% w/w, 2 h), elastase (lane 3, 1% w/w, 30 min), protease V8 (lane
4, 10% w/w, 2 h), subtilisin (lane 5, 10% w/w, 1 h), bromelain (lane 6, 10%
w/w, 1 h), thermolysin (lane 7, 10% w/w, 2 h), dispase (lane 8, 5% w/w,
30 min), endoproteinase Asp-N (lane 9, 1% w/w, 2 h). On the left side,
the positions of the M protein (26 kDa) and of the fragments resulting
from trypsin digestion (21 kDa) and from thermolysin digestion (12 and
8 kDa) are indicated. On the right side, SDS–PAGE gel (18%) of native
VSV M protein and thermolysin-digested M after removal of salt by
dialysis.
FIG. 2. Fragments produced by thermolysin-limited proteolysis of M
equencing. The two central fragments are colored in light gray and limited b
re colored in dark gray and limited by up-pointing arrows.RESULTS
Limited proteolysis
M protein was purified from virions, stored in 700 mM
NaCl to prevent any aggregation (McCreedy et al., 1990),
and submitted to a number of proteases. The duration of
the digestion and the M:protease ratio were adjusted to
isolate protease-resistant cores. The results were ana-
lyzed on SDS–PAGE gels and are shown in Fig. 1.
Papain and proteinase K did not yield any resistant
fragment but the other proteases gave rise to two pat-
terns of cleavage. First, cleavage by elastase, clostripain,
trypsin, and endoproteinase Lys-C leads to a 24-kDa
fragment, which evolves to a 21-kDa proteolytic-resistant
core. The trypsin-resistant fragment has already been
characterized and corresponds to the digestion of the
N-terminal part of the protein (Gaudin et al., 1995; Ogden
et al., 1986; Pal et al., 1985). Second, cleavage by ther-
olysin, dispase, subtilisin, bromelain, endoproteinase
sp-N, and protease V8 leads to two fragments of 12 and
kDa apparent molecular mass. This new pattern of
leavage was investigated further. As cleavage with ther-
olysin gives a better yield, we chose to characterize
nd purify the fragments obtained with this protease.
haracterization of the thermolysin digestion product
f VSV M
The characterization was done both by MALDI-TOF
ass spectrometry and by amino-terminal sequencing.
he results show that the faster migrating 8-kDa frag-
ent corresponds to the central zone of the protein and
hat the slower 12-kDa fragment corresponds to its C-
erminal part (Fig. 2). Amino-terminal sequencing indi-
ates that the central fragment has one amino-terminal
xtremity (at Val 48), whereas the C-terminal fragment
as three possible N-terminal extremities (at Val 122, Leu
23, or Ala 124). Mass spectrometry indicates that the
entral fragment has two C-terminal extremities (at Lys
17 or Ala 121), whereas we could not deconvolute the
pectrum of the C-terminal fragment. According to the
pecificity of thermolysin, there are two potential C-ter-
in as deduced from mass spectrometry analysis and amino-terminalprote
y down-pointing arrows. The six potential carboxy-terminal fragments
t
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310 GAUDIER, GAUDIN, AND KNOSSOWminal extremities to the C-terminal fragment (at His 227
or Lys 229). To summarize, cleavage of M by thermolysin
leads to two central fragments (48–117 and 48–121) and
possibly to six C-terminal fragments (starting at residue
122, 123, or 124 and most likely ending at residue 227 or
229). As the cleavage zone between the central and the
C-terminal fragments (ATPAVLA, residues 118–124) con-
tains five potential cleavage sites, this heterogeneity
corresponds to the known specificity of thermolysin.
To characterize further the thermolysin cleavage prod-
uct of M, we studied its behavior by gel filtration (Fig. 3).
Preliminary experiments showed that both fragments
comigrate on a gel filtration column. To determine
whether these fragments were still associated or
whether they could not be separated due to similar
hydrodynamic properties, we estimated the Stokes’ ra-
dius of the fraction containing the fragments and com-
pared the molecular weight of the fragments to that of a
spherical protein with identical Stokes’ radius. The mea-
sured radius was ca. 20 Å (Fig. 3); this corresponds to a
20-kDa spherical protein, which suggests that the 12-
and 8-kDa fragments are associated in the digestion
product.
Finally, to reduce the heterogeneity of the M thermo-
lysin digestion product, we used anion-exchange chro-
matography. At pH 8.5, we obtained two main fractions
that both contained an 8- and a 12-kDa fragment. The
first fraction flows through the column and the second is
eluted at 70 mM NaCl. Those fractions were character-
ized by mass spectrometry and we found that the central
fragment of the latter is pure and spans residues 48 to
FIG. 3. Stokes radius of M protein cleaved by trypsin (Mt) and
thermolysin (Mth). A FPLC Sephadex 75 column was calibrated using
a series of standard proteins: ribonuclease A (R), chymotrypsinogen A
(C), ovalbumin (O), and bovine serum albumin (B). Upon gel filtration, a
linear relationship y 5 57.4 x 2 21.6 was noted between the Stokes
radii of standard proteins and (2log KL av)
1/2. Stokes radii of Mt and Mth
were determined graphically to be 21 and 20 Å, respectively.121 of M. The C-terminal fragment is heterogeneous in
both fractions.M thermolysin-resistant core is not recruited in M
aggregates
The in vitro aggregation of the matrix protein has been
extensively studied using light scattering (Gaudin et al.,
1995, 1997). Although the trypsin-resistant core of the
protein did not aggregate under conditions where the
whole protein does, it could still be incorporated in ag-
gregates when whole M protein was added to its solu-
tions. We characterized the aggregation of the thermoly-
sin-resistant core of M using the same light-scattering
method. We added small amounts of purified M protein
to a solution of its thermolysin-resistant core and re-
corded the plateaus reached by scattered light. Figure 4
shows that, as opposed to its trypsin-resistant core,
thermolysin cleaved M does not allow the growth of
preformed aggregates.
M thermolysin-resistant core crystallization
Initial crystallization trials with whole M and with its
trypsin-resistant core were unsuccessful. The thermoly-
sin digestion product that eluted at 70 mM NaCl during
anion-exchange chromatography was used for further
crystallization attempts. It was dialyzed against 20 mM
Tris–HCl, pH 8.5, 100 mM NaCl and concentrated to 5
mg/ml. Crystals were obtained using the vapor diffusion
method with hanging drops. A 2-ml 1:1 protein:well mix-
ure was equilibrated with a well containing 24% PEG
000 monomethylether, 0.2 M sodium acetate, 0.1 M
aCl, and 0.1 M Tris–HCl, pH 8.5. Crystals grew in 3
eeks up to a size of 80 3 80 3 50 mm (Fig. 5); they
FIG. 4. M cleaved by thermolysin is not recruited in aggregates.
Increasing amounts of untreated M protein (1 mg/ml) were added in a
spectrofluorimeter cuvette containing 1 ml of 20 mM Tris–HCl, pH 8, 70
mM NaCl (control), or 1 ml of 20 mM Tris–HCl, pH 8, 70 mM NaCl plus
M trypsin-resistant fragment at 100 mg/ml (Mt), or 1 ml of 20 mM
Tris–HCl, pH 8, 70 mM NaCl plus M thermolysin-resistant fragment at
100 mg/ml (Mth). For each experimental point, initial light scattering,
due to the buffer (control) or to nonaggregated digested M protein (Mt
and Mth), was subtracted.
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311CRYSTALLIZATION OF VSV MATRIX PROTEINdiffract to 2-Å resolution. The space group symmetry is
P42 12; unit cell dimensions are a 5 b 5 80.7 Å, c 5
1.7 Å. The volume of the asymmetric unit is consistent
ith a content of one protein molecule per asymmetric
nit; the corresponding volume per dalton in the crystals
s 2.0 Å3, in the range usually found in protein structures
Matthews, 1968).
DISCUSSION
Viral matrix proteins from negative-stranded RNA vi-
uses autoassociate in vitro (Gaudin et al., 1995; Mc-
reedy et al., 1990; Heggeness et al., 1982; Hewitt and
ermut, 1977) and in vivo (Flood et al., 2000; Fujiyoshi et
l., 1994; Zhao et al., 1998), a feature shared by retroviral
ag precursor proteins (Morikawa et al., 1995; Nermut et
l., 1994). In the case of VSV, this self-assembly property
f the matrix protein results in its low solubility and is
ikely to be one of the causes of the difficulties experi-
nced in its crystallization, probably because the aggre-
ates formed are neither ordered nor homogeneous
nough to yield crystals. We have used controlled pro-
eolysis to produce fragments of the VSV matrix protein
acking the whole protein self-association properties.
hermolysin cleaves M in a hydrophobic peptide (resi-
ues 120–124); we deduce from this result that the 120–
24 peptide is located on the surface of the protein and
acks a stable secondary structure. The cleavage intro-
uces two charges on the surface of the protein at the
ew N- and C-termini and therefore changes the local
tructure. The resulting product, consisting of residues
8 to 121 and 122 to 227 of M, does not self-associate nor
s it recruited in preformed aggregates; this is in contrast
o the VSV M trypsin-resistant core, which comprises
esidues 44 to 229 of M (Pal et al., 1985). The simplest
xplanation for this change is that the hydrophobic pep-
ide spanning residues 120 to 124 is directly involved in
FIG. 5. Crystal of the VSV matrix protein (dimensions 80 3 80 3 50
mm).SV matrix protein self-association.
Crystallization has been the limiting step in the struc-
m
tural study of VSV M since neither the whole protein nor
ts trypsin-resistant core could be crystallized. This is
espite the fact that in the absence of nucleation sites or
t high salt concentrations both proteins were monodis-
erse, as demonstrated by small-angle neutron scatter-
ng, light scattering, and analytical ultracentrifugation
Barge et al., 1996; Gaudin et al., 1995; McCreedy et al.,
990). Monodispersity and success in the crystallization
f a protein have been observed to strongly correlate
Ferre-D’Amare and Burley, 1994), but in the case of VSV
, which self-associates in the presence of nuclei, we
ound an additional criterion for successful crystallization
f its digestion products, namely, the inability to allow
rowth of aggregates, a property easily tested with light
cattering. This criterion may find other applications in
he study of other proteins that self-associate, such as
he matrix proteins of negative-stranded RNA viruses or
etroviral Gag precursor proteins.
Limited proteolysis of VSV M provides two different
ieces of structural information on this protein in ad-
ance and independently of its X-ray atomic structure.
irst, the cleavage pattern of VSV M shows that the
mino-terminal part of the protein is sensitive to a wide
ange of proteases and thus is likely to be flexible and to
ack an extensive and stable secondary structure. Sec-
nd, the Stokes’ radii of the M protein cleaved by trypsin
nd thermolysin (21 and 20 Å, respectively) differ sub-
tantially from the Stokes’ radius of whole VSV M, which
as estimated by three different methods to be between
0 and 36 Å (Barge et al., 1996). The Stokes’ radius of a
pherical protein of the same molecular weight as whole
is 21 Å. The likely explanation for that difference is that
SV M is composed of two domains, a globular carboxy-
erminal domain and a largely unstructured amino-termi-
al domain (comprising ca. 50 residues). The latter do-
ain accounts for the large difference between the hy-
rodynamic properties of whole M and its proteolytic
ragments.
Three structures of matrix proteins, which all corre-
pond to a different fold, have been described. The
tructure of the matrix domain (MA) of the retroviral Gag
IV protein has been determined by both NMR and X-ray
rystallography (Hill et al., 1996; Massiah et al., 1994). It
is composed of a globular core with a C-terminal exten-
sion that was found to be an unstructured coil by NMR
and a-helical by crystallography (Massiah et al., 1996).
his difference might be due to crystal contacts or to the
rimerization of the protein in the crystals. Whatever the
ase, this extension has at least two possible conforma-
ions; it is therefore likely to be flexible. Both structures of
he matrix protein of influenza (M1) and Ebola (VP40)
iruses have been determined by X-ray crystallography.
he VP40 protein was crystallized after proteolytic re-
oval of a flexible N-terminal tail (Dessen et al., 2000);
he crystallized M1 fragment was found to lack the C-
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312 GAUDIER, GAUDIN, AND KNOSSOWterminal part of the protein (Sha and Luo, 1997; Arzt et al.,
2001), which implies a weak interaction between M1 N-
and C-terminal domains. Thus, all the known structures
of matrix proteins reveal substantial flexibility; the data
reported here and previously (Gaudin et al., 1997) show
that VSV M shares the same property, which may be
important for the common functions of matrix proteins in
viral budding and assembly.
MATERIALS AND METHODS
Virus and cells
Wild-type VSV (Orsay strain, Indiana serotype) was
propagated in BSR cells, a clone of BHK 21. Cells were
grown in Eagle’s minimal essential medium supple-
mented with 10% calf serum. Twenty-four hours after
infection, virus particles were pelleted from the culture
supernatant through 30% glycerol in 10 mM Tris–HCl, pH
7.5, 50 mM NaCl, 1 mM EDTA and resuspended in TD
buffer (137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 25
mM Tris–HCl, pH 7.5).
Proteases
Trypsin, bromelain, and subtilisin were obtained from
Sigma. Elastase, protease V8, thermolysin, dispase, and
endoproteinase Asp-N were from Boehringer Mannheim.
Endoproteinase Asp-N was diluted according to the
manufacturer’s instructions to 0.04 mg/ml in 10 mM Tris–
HCl, pH 7.5. Other proteases were dissolved at a 1 mg/ml
concentration in 10 mM sodium phosphate, pH 7.0. Pro-
tease aliquots were stored frozen and discarded after
each partial use.
M protein purification
M protein was purified as previously described (Gau-
din et al., 1995). Briefly, 1 vol of virus in TD buffer (viral
protein concentration: ca. 10 mg/ml) was added to 1 vol
of solubilization buffer (1 M NaCl, 40 mM Tris–HCl, pH
8.0, 1.2% CHAPS). After a 30-min incubation at 37°C, the
mixture was overlaid on 20% sucrose in 0.5 M NaCl, 40
mM Tris–HCl, pH 8.0, 0.5% CHAPS and centrifuged for 50
min at 35,000 rpm in a SW41 rotor (Beckman) to separate
solubilized proteins from insoluble material. The super-
natant, containing mainly VSV M and G proteins but also
viral lipids, was diluted four times with 20 mM Tris–HCl,
pH 8, 0.5% CHAPS and loaded on a phosphocellulose
column (P11, Whatman); G protein and residual viral
contaminants flow through. After a wash with 150 mM
NaCl, M protein was eluted in 0.7 M NaCl, 50 mM
Tris–HCl, pH 8.0. At this stage, SDS–PAGE analysis indi-
cated that M protein is essentially free of contaminants.
ProteolysisM protein (1 mg/ml) in 0.7 M NaCl, 50 mM Tris–HCl, pH
8.0, was incubated at 37°C with varying weight ratios of mprotease and for different lengths of time. The reaction
was stopped by adding an excess of protease inhibitor:
2 mM PMSF for trypsin, subtilisin, elastase, and protease
V8; 5 mM EDTA for thermolysin, dispase, and endopro-
teinase Asp-N; and 2 mM iodoacetamide for bromelain.
Electrophoresis sample buffer was added to aliquots of
the samples, which were immediately boiled. Analysis
was performed using 18% SDS–PAGE.
Purification of M cleaved by thermolysin
M fragments were dialyzed overnight against 20 mM
Tris–HCl, pH 8.5, loaded on a mono Q 5/5 column (Phar-
macia), and eluted with a 10-ml 0–0.15 M NaCl gradient
in 20 mM Tris–HCl, pH 8.5. The fractions containing M
fragments were identified by PAGE, dialyzed against 100
mM NaCl, 20 mM Tris–HCl, pH 8.5, and characterized by
mass spectrometry.
Mass spectrometry and amino-terminal sequencing
Mass spectrometry was performed on a Brucker Biflex
MALDI-TOF mass spectrometer. The samples were dia-
lyzed against 10 mM phosphate buffer, pH 8, and mixed
with sinapinic acid as a matrix. Amino-terminal sequenc-
ing was performed on an ABI 407A sequencer. The
samples were eluted from a SDS–PAGE gel on a PVDF
membrane (Pharmacia) by semidry electrophoresis and
five sequencing cycles were performed.
Gel filtration chromatography
To estimate the Stokes radius (R s) of M protein
leaved by trypsin and thermolysin, proteins were sub-
ected to gel filtration on an FPLC Sephadex 75 column
Pharmacia). Samples were run on the column after
quilibration in 20 mM Tris–HCl, pH 8, 1 mM EDTA, 700
M NaCl at 0.5 ml/min. Standard proteins used to cali-
rate the column were ribonuclease A (R s 5 16.4 Å),
hymotrypsinogen A (R s 5 20.9 Å), ovalbumin (R s 5 30.5
), and bovine serum albumin (R s 5 35.5 Å) (gel filtration
calibration kit (Pharmacia)). Gel filtration data are pre-
sented either as elution volumes or as the molecular
sieve coefficient, K av, a parameter calculated as (V e 2
V0)/(V t 2 V0), where V e represents the elution volume
orresponding to the peak concentration of a protein, V 0
is the void volume of the column, and V t is the total
volume of the gel bed. The void volume was determined
by measuring the elution volume with blue dextran. The
Stokes radius of the proteins was determined graphically
on a (log K av)
1/2 versus Stokes radius plot (Siegel and
onty, 1966) constructed with the above-mentioned
tandard proteins.
ight-scattering studiesLight-scattering increase due to aggregation was
easured at 400 nm using a Perkin–Elmer L550B spec-
T
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313CRYSTALLIZATION OF VSV MATRIX PROTEINtrofluorimeter (Gaudin et al., 1995). The cell contained 1
ml of a solution of M thermolysin or M trypsin-resistant
core at a 100 mg/ml protein concentration in 20 mM
ris–HCl, pH 8.0, 70 mM NaCl. Native M protein, 1 mg/ml
n 20 mM Tris–HCl, pH 8.0, 700 mM NaCl, was added to
he cell in 2-ml steps. The signal corresponding to the
plateau reached by the diffused light was recorded be-
tween successive steps.
ACKNOWLEDGMENTS
We thank Anne Flamand for support, Christine Maheu for the pro-
duction of VSV, and Diep Le for determining amino-terminal sequences.
We gratefully acknowledge Richard Kahn’s help with the use of the FIP
beamline at ESRF (Grenoble). This work is supported by CNRS (UPR
9053 and UPR 9063) and by the “Programme de Recherche Fondamen-
tale en Microbiologie, Maladies Infectieuses et Parasitaires.”
REFERENCES
Arzt, S., Baudin, F., Barge, A., Timmins, P., Burmeister, W. P., and
Ruigrok, R. W. H. (2001). Combined results from solution studies on
intact influenza virus M1 protein and from a new crystal form of its
N-terminal domain show that M1 is an elongated monomer. Virology
279, 439–446.
Barge, A., Gagnon, J., Chaffotte, A., Timmins, P., Langowsky, J., Ruigrok,
R., and Gaudin, Y. (1996). Rod-like shape of vesicular stomatitis virus
matrix protein. Virology 219, 465–470.
Bergmann, J., and Fusco, P. (1988). The M protein of vesicular stomatitis
virus associates specifically with the basolateral membranes of
polarized epithelial cells independently of the G protein. J. Cell Biol.
107, 1707–1715.
Black, B., Brewer, G., and Lyles, D. (1994). Effect of vesicular stomatitis
virus matrix protein on host-directed translation in vivo. J. Virol. 68,
555–560.
Black, B., and Lyles, D. (1992). Vesicular stomatitis virus matrix protein
inhibits host cell-directed transcription of target genes in vivo. J. Virol.
66, 4058–4064.
Black, B., Rhodes, R., McKenzie, M., and Lyles, D. (1993). The role of
vesicular stomatitis virus matrix protein in inhibition of host-directed
gene expression is genetically separable from its function in virus
assembly. J. Virol. 67, 4814–4821.
Blondel, D., Harmison, G., and Schubert, M. (1990). Role of matrix
protein in cytopathogenesis of vesicular stomatitis virus. J. Virol. 64,
1716–1725.
Chong, L., and Rose, J. (1993). Membrane association of functional
vesicular stomatitis virus matrix protein in vivo. J. Virol. 67, 407–414.
Chong, L., and Rose, J. (1994). Interaction of normal and mutant vesic-
ular stomatitis virus matrix proteins with the plasma membrane and
nucleocapsids. J. Virol. 68, 441–447.
Clinton, G. M., Little, S. P., Hagen, F. S., and Huang, A. S. (1978). The
matrix (M) protein of vesicular stomatitis virus regulates transcrip-
tion. Cell 15, 1455–1462.
Craven, R. C., Harty, R. N., Paragas, J., Palese, P., and Wills, J. W. (1999).
Late domain function identified in the vesicular stomatitis virus M
protein by use of rhabdovirus–retrovirus chimeras. J. Virol. 73, 3359–
3365.
Dessen, A., Volchkov, V., Dolnik, O., Klenk, H. D., and Weissenhorn, W.
(2000). Crystal structure of the matrix protein VP40 from Ebola virus.
EMBO J. 19, 4228–4236.
Ferre-D’Amare, A. R., and Burley, S. K. (1994). Use of dynamic light
scattering to assess crystallizability of macromolecules and macro-
molecular assemblies. Structure 2, 357–359.
Flood, E. A., McKenzie, M. O., and Lyles, D. S. (2000). Role of M proteinaggregation in defective assembly of temperature-sensitive M pro-
tein mutants of vesicular stomatitis virus. Virology 278, 520–533.
Fujiyoshi, Y., Kume, N. P., Sakata, K., and Sato, S. B. (1994). Fine
structure of influenza A virus observed by electron cryo-microscopy.
EMBO J. 13, 318–326.
Gaudin, Y., Barge, A., Ebel, C., and Ruigrok, R. (1995). Aggregation of
VSV M protein is reversible and mediated by nucleation sites: Impli-
cation for viral assembly. Virology 206, 28–37.
Gaudin, Y., Sturgis, J., Doumith, M., Barge, A., Robert, B., and Ruigrok, R.
(1997). Conformational flexibility and polymerisation of vesicular sto-
matitis virus matrix protein. J. Mol. Biol. 274, 816–825.
Harty, R. N., Brown, M. E., Wang, G., Huibregtse, J., and Hayes, F. P.
(2000). A PPxY motif within the VP40 protein of Ebola virus interacts
physically and functionally with a ubiquitin ligase: Implications for
filovirus budding. Proc. Natl. Acad. Sci. USA 97, 13871–13876.
Harty, R. N., Paragas, J., Sudol, M., and Palese, P. (1999). A proline-rich
motif within the matrix protein of vesicular stomatitis virus and rabies
virus interacts with WW domains of cellular proteins: Implications for
viral budding. J. Virol. 73, 2921–2929.
Heggeness, M. H., Smith, P. R., and Choppin, P. W. (1982). In vitro
assembly of the nonglycosylated membrane protein (M) of Sendai
virus. Proc. Natl. Acad. Sci. USA 79, 6232–6236.
Her, L., Lund, E., and Dahlberg, J. (1997). Inhibition of Ran guanosine
triphosphate-dependent nuclear transport by the matrix protein of
vesicular stomatitis virus. Science 276, 1845–1848.
Hewitt, J. A., and Nermut, M. V. (1977). A morphological study of the
M-protein of Sendai virus. J. Gen. Virol. 34, 127–136.
Hill, C. P., Worthylake, D., Banckroft, D. P., Christensen, A. M., and
Sundquist, W. I. (1996). Crystal structure of the trimeric human im-
munodeficiency virus type 1 matrix protein: Implications for mem-
brane association and assembly. Proc. Natl. Acad. Sci. USA 93,
3099–3104.
Jayakar, H. R., Murti, K. G., and Whitt, M. (2000). Mutations in the PPPY
motif of vesicular stomatitis virus matrix protein reduce virus budding
by inhibiting a late step in virion release. J. Virol. 74, 9818–9827.
Lenard, J. (1996). Negative-strand virus M and retrovirus MA proteins:
All in a family? Virology 216, 289–298.
Lenard, J., and Vanderoef, R. (1990). Localization of the membrane-
associated region of vesicular stomatitis virus M protein at the N
terminus, using the hydrophobic, photoreactive probe 125I-TID. J. Vi-
rol. 64, 3486–3491.
Martinet, C., Combard, A., Printz-Ane, C., and Printz, P. (1979). Envelope
proteins and replication of vesicular stomatitis virus: In vivo effects of
RNA1 temperature-sensitive mutations on viral RNA synthesis. J. Vi-
rol. 29, 123–133.
Massiah, M. A., Starich, M. R., Paschall, C., Summers, M. F., Chris-
tensen, A. M., and Sundquist, W. I. (1994). Three-dimensional struc-
ture of the human immunodeficiency virus type 1 matrix protein. J.
Mol. Biol. 244, 198–223.
Massiah, M. A., Worthylake, D., Christensen, A. M., Sundquist, W. I., Hill,
C. P., and Summers, M. F. (1996). Comparison of the NMR and X-ray
structures of the HIV-1 matrix protein: Evidence for conformational
changes during viral assembly. Protein Sci. 5, 2391–2398.
Matthews, B. W. (1968). Solvent content of protein crystals. J. Mol. Biol.
33, 491–497.
McCreedy, J., McKinnon, K., and Lyles, D. (1990). Solubility of vesicular
stomatitis virus M protein in the cytosol of infected cells or isolated
from virions. J. Virol. 64, 902–906.
Melki, R., Gaudin, Y., and Blondel, D. (1994). Interaction between tubulin
and the viral matrix protein of vesicular stomatitis virus: Possible
implication in the viral cytopathic effect. Virology 202, 339–347.
Morikawa, Y., Kishi, T., Zhang, W. H., Nermut, M. V., Hockley, D. J., and
Jones, I. M. (1995). A molecular determinant of human immunodefi-
ciency virus particle assembly located in matrix antigen p17. J. Virol.
69, 4519–4523.
SS
v
Y
Y
Z
314 GAUDIER, GAUDIN, AND KNOSSOWNermut, M. V., Hockley, D. J., Jowett, J. B., Jones, I. M., Garreau, M., and
Thomas, D. (1994). Fullerene-like organization of HIV gag-protein
shell in virus-like particles produced by recombinant baculovirus.
Virology 198, 288–296.
Newcomb, W., Tobin, G., McGowan, J., and Brown, J. (1982). In vitro
reassembly of vesicular stomatitis virus skeletons. J. Virol. 41, 1055–
1062.
Newcomb, W. W., and Brown, J. C. (1981). Role of the vesicular stoma-
titis virus matrix protein in maintaining the viral nucleocapsid in the
condensed form found in native virions. J. Virol. 39, 295–299.
Ogden, J., Pal, R., and Wagner, R. (1986). Mapping regions of the matrix
protein of vesicular stomatitis virus which bind to ribonucleocapsids,
liposomes and monoclonal antibodies. J. Virol. 58, 860–868.
Pal, R., Grinnell, B. W., Snyder, R. M., and Wagner, R. R. (1985). Regu-
lation of viral transcription by the matrix protein of vesicular stoma-
titis virus probed by monoclonal antibodies and temperature-sensi-
tive mutants. J. Virol. 56, 386–394.
ha, B., and Luo, M. (1997). Structure of a bifunctional membrane-RNA
binding protein, influenza virus matrix protein M1. Nat. Struct. Biol. 4,
239–244.iegel, L. M., and Monty, K. J. (1966). Determination of molecular
weights and frictional ratios of proteins in impure systems by use of
gel filtration and density gradient centrifugation. Application to crude
preparations of sulfite and hydroxylamine reductases. Biochim. Bio-
phys. Acta 112, 346–362.
on Kobbe, C., van Deursen, J. M., Rodrigues, J. P., Sitterlin, D., Bachi,
A., Wu, X., Wilm, M., Carmo-Fonseca, M., and Izaurralde, E. (2000).
Vesicular stomatitis virus matrix protein inhibits host cell gene
expression by targeting the nucleoporin nup98. Mol. Cell 6, 1243–
1252.
e, Z., Sun, W., Suryanarayana, K., Justice, P., Robinson, D., and
Wagner, R. (1994). Membrane-binding domains and cytopathogen-
esis of the matrix protein of vesicular stomatitis virus. J. Virol. 68,
7386–7396.
uan, H., Yoza, B., and Lyles, D. (1998). Inhibition of host RNA polymer-
ase II-dependent transcription by vesicular stomatitis virus results
from inactivation of TFIID. Virology 251, 383–392.
hao, H., Ekstrom, M., and Garoff, H. (1998). The M1 and NP proteins of
influenza A virus form homo- but not heterooligomeric complexes
when coexpressed in BHK-21 cells. J. Gen. Virol. 79, 2435–2446.
